BlossomHill Therapeutics, Inc.
Status: Publicly traded
Last reviewed: October 2026
Direct answer
BlossomHill Therapeutics, Inc. is publicly traded on NASDAQ under the ticker BLSM.
Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.
Can you invest in BlossomHill Therapeutics, Inc.?
Yes. BlossomHill Therapeutics, Inc. trades publicly on NASDAQ as BLSM.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for BlossomHill Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.